Skip to content

Abnormal Circulating Fatty Acid Anion Concentration C4021209

Published: July 22, 2026Updated: August 20, 2026

A finding based on abnormal levels of fatty acid anions in the blood, which may indicate metabolic or nutritional issues. Management involves addressing the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pancreatitis

Inflammation of the pancreas caused by extremely high triglyceride levels, leading to severe abdominal pain.

Seek immediate medical attention for severe upper abdominal pain radiating to the back, especially with nausea and vomiting.

!

Chest pain

Pain or discomfort in the chest area that may indicate cardiovascular complications from lipid abnormalities.

Seek emergency medical care immediately for chest pain, especially if accompanied by shortness of breath, sweating, or pain radiating to the arm or jaw.

Fatigue

(constitutional)

Persistent tiredness and lack of energy due to impaired energy metabolism from abnormal fatty acid processing.

Frequency: 70-80% of patients

Elevated blood lipids

(cardiovascular)

Abnormally high levels of fatty substances in the blood, detected through laboratory testing.

Frequency: 60-70% of patients

Xanthomas

(dermatologic)

Yellowish deposits of fat under the skin, often appearing as small bumps on elbows, knees, or heels.

Frequency: 40-50% of patients

Abdominal discomfort

(gastrointestinal)

General discomfort or mild pain in the abdominal region related to lipid metabolism disturbances.

Frequency: 35-45% of patients

Memory difficulties

(neurologic)

Mild cognitive issues or difficulty concentrating due to metabolic changes affecting brain function.

Frequency: 15-20% of patients

Muscle weakness

(musculoskeletal)

Reduced muscle strength or endurance, particularly after physical exertion, related to altered fatty acid oxidation.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Structured exercise program

Regular aerobic and resistance exercise improves insulin sensitivity and fatty acid metabolism, normalizing circulating levels.

lifestyle
3

Mediterranean-style low-glycemic diet

Emphasizing whole grains, omega-3 rich fish, healthy fats, and limiting refined carbohydrates improves lipid metabolism.

dietary

Additional treatment options

Lipid-lowering therapy

Pharmacological agents such as statins or fibrates may be indicated when dietary and lifestyle measures are insufficient.

medication

Fasting lipid profile testing

Regular blood lipid panels to track fatty acid anion concentrations and assess cardiovascular risk trajectory.

monitoring

Omega-3 fatty acid supplementation

Purified fish oil or algae-derived omega-3 supplements may help normalize fatty acid profiles when dietary intake is inadequate.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Fatty Acid Anion Concentration C4021209?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S179-S218.

guideline2024View source →
2

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350.

guideline2019View source →
3

Rohde DSF, Bombo RP, Cavalcanti LC, et al. Fatty Acid Metabolism in Metabolic Syndrome and Cardiovascular Disease: An Updated Review. Arch Med Res. 2023;54(5):102838.

review2023View source →
4

World Health Organization. WHO Global Noncommunicable Diseases (NCD) Implementation Research and Advocacy Grant. Geneva: WHO; 2023.

guideline2023View source →
5

Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2017;136(3):e1-e23.

meta_analysis2017View source →
6

Sperling MA. Pediatric Endocrinology. 5th ed. Philadelphia: Elsevier; 2020. Chapter 12: Disorders of Fatty Acid Oxidation.

textbook2020
7

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015;9(6):S1-122.

position_statement2015View source →
8

Calder PC, Ahluwalia N, Brouns F, et al. Dietary Factors and Low-Grade Inflammation in Relation to Overweight and Obesity. Br J Nutr. 2018;120(1):5-32.

review2018View source →
9

Expert Consensus on the Management of Hypertriglyceridemia in Clinical Practice. Endocr Pract. 2021;27(8):819-834.

consensus2021View source →
10

NCT03842255. Study of Volanesorsen in Patients With Hypertriglyceridemia and Pancreatitis. ClinicalTrials.gov. 2019.

clinical_trial2019View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Fatty Acid Anion Concentration C4021209. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy